✅ Direct GP referral — when you can refer without a sleep physician

Under MBS 12203 and 12250, you can refer directly if one of these combinations is met and documented in the patient record:

STOP-Bang score ≥3 AND Epworth Sleepiness Scale (ESS) ≥8
— OR —
OSA50 score ≥5 AND Epworth Sleepiness Scale (ESS) ≥8
— OR —
Berlin Questionnaire high risk AND Epworth Sleepiness Scale (ESS) ≥8
Documentation required: Full screening questionnaire responses and scores must be recorded in the patient's clinical record — these are auditable. If questionnaires are incomplete, the sleep provider can administer them, but it is cleaner if done at the referral stage.

Level 1 vs Level 2 — which study to request

The sleep provider makes the final determination, but you can specify if clinically indicated.

🏥 Level 1 — Attended
MBS 12203 — $685.95 (75% benefit = $514.50)
  • Performed in sleep laboratory
  • Technician in continuous attendance
  • Full polysomnography: EEG, EOG, EMG, ECG, airflow, O₂, respiratory effort, CO₂
  • Minimum 8 hours duration (including setup)
  • Manual scoring or manually corrected computerised scoring in ≤1 min epochs
  • Report by qualified sleep medicine practitioner
🏠 Level 2 — Unattended
MBS 12250 — $391.10 (75% benefit)
  • Performed at home or without continuous tech presence
  • Equipment applied by technician where possible; patient-applied with written instructions if not
  • Same channel requirements as Level 1 (EEG, EOG, EMG, ECG, airflow, O₂, respiratory effort)
  • Minimum 8 hours
  • Report by qualified sleep medicine practitioner
  • More accessible, lower cost to patient
⚠️ No MBS items for Level 3 or Level 4 (HSAT). Home Sleep Apnoea Tests using simplified devices (no EEG) are not funded under Medicare as of July 2026. Some private sleep providers offer these; patients pay out of pocket. Do not confuse Level 2 (full PSG, unattended) with HSAT — they are different.

Relative contraindications to Level 2 (home/unattended) study

Per Australasian Sleep Association guidelines. If any of these apply, consider specifying Level 1 or referring to sleep physician for triage:

Referral workflow

1
Administer screening tools
STOP-Bang (or OSA50 or Berlin) + Epworth. Record all responses and scores in notes.
2
Check if direct referral criteria met
Any validated combination (see above) with ESS ≥8 → direct referral. If not met → refer to sleep physician/respiratory physician for assessment.
3
Assess for Level 2 contraindications
If none → Level 2 (home/unattended) is suitable for most patients with suspected OSA. If contraindicated → request Level 1 or let sleep provider decide.
4
Write referral
Include: clinical indication, screening scores (with full questionnaire responses or note they're in the chart), any relevant comorbidities, whether Level 1 is specifically required. Sleep provider can determine study type if unspecified.
5
Results and treatment
Results must be discussed with patient by a medical practitioner before initiating therapy (CPAP, positional therapy, etc.). GP can manage ongoing CPAP — specialist not required for straightforward OSA.

Other sleep study MBS items (for reference)

Item Description Fee
12203 Diagnostic sleep study — Level 1 (attended, adult) $685.95
12250 Diagnostic sleep study — Level 2 (unattended, adult) $391.10
12204 Titration study — Level 1 (CPAP/BiPAP, adult) Derived
12210 Diagnostic sleep study — Level 1 (paediatric, attended) See MBS
12254 Multiple Sleep Latency Test (MSLT) — adult (narcolepsy) See MBS
Level 3/4 Home Sleep Apnoea Test (HSAT) — no MBS items available Private only

Fees as per MBS July 2026. 75% benefit applies to diagnostic items 12203 and 12250. Verify at mbsonline.gov.au.

Screening tools (use in clinic or send before appointment)

Clinician reference only. This page summarises MBS rules and clinical guidelines for GP reference. It does not constitute clinical advice. MBS item descriptors, fees, and eligibility criteria should be verified against current MBS Online before billing. Clinical decisions should be made in the context of individual patient assessment and current guidelines.